Biogen Inc BIIB:NASDAQ

RT Quote | Last NASDAQ LS, VOL From CTA | USD
after hours iconAfter Hours: Last | 08/12/22 EDT
220.99UNCH (UNCH)
Volume
16,027
Close
220.99quote price arrow up+2.77 (+1.27%)
Volume
752,132
52 week range
187.16 - 351.86
Loading...
  • Open218.58
  • Day High222.17
  • Day Low218.58
  • Prev Close218.22
  • 52 Week High351.86
  • 52 Week High Date08/18/21
  • 52 Week Low187.16
  • 52 Week Low Date05/09/22

Key Stats

  • Market Cap32.364B
  • Shares Out146.45M
  • 10 Day Average Volume0.87M
  • Dividend-
  • Dividend Yield-
  • Beta0.40
  • YTD % Change-7.89

KEY STATS

  • Open218.58
  • Day High222.17
  • Day Low218.58
  • Prev Close218.22
  • 52 Week High351.86
  • 52 Week High Date08/18/21
  • 52 Week Low187.16
  • 52 Week Low Date05/09/22
  • Market Cap32.364B
  • Shares Out146.45M
  • 10 Day Average Volume0.87M
  • Dividend-
  • Dividend Yield-
  • Beta0.40
  • YTD % Change-7.89

RATIOS/PROFITABILITY

  • EPS (TTM)14.01
  • P/E (TTM)15.78
  • Fwd P/E (NTM)14.13
  • EBITDA (TTM)3.397B
  • ROE (TTM)18.20%
  • Revenue (TTM)10.634B
  • Gross Margin (TTM)77.34%
  • Net Margin (TTM)14.61%
  • Debt To Equity (MRQ)61.29%

EVENTS

  • Earnings Date10/18/2022(est)
  • Ex Div Date-
  • Div Amount-
  • Split Date-
  • Split Factor-

Related Video

VIDEO11:1511:15
Friday, August 5, 2022: Cramer likes these stocks after strong jobs report

Profile

MORE
Biogen Inc. is a global biopharmaceutical company. It is focused on discovering, developing and delivering therapies for people living with serious neurological and neurodegenerative diseases as well as related therapeutic adjacencies. It has a portfolio of medicines to treat multiple sclerosis (MS), spinal muscular atrophy (SMA) and Alzheimer's disease. Its marketed products include TECFIDERA, VUMERITY, AVONEX, PLEGRIDY, TYSABRI and FAMPYRA for the treatment of MS; SPINRAZA...
Stelios Papadopoulos Ph.D.
Independent Chairman of the Board
Michel Vounatsos
Chief Executive Officer, Director
Michael McDonnell
Chief Financial Officer, Executive Vice President
Alphonse Galdes Ph.D.
Executive Vice President, Pharmaceutical Operations and Technology
Rachid Izzar
Executive Vice President, Head of Alzheimers Disease and Dementia Business Unit
Address
225 Binney Street
Cambridge, MA
02142
United States

Top Peers

SYMBOLLASTCHG%CHG
ILMN
Illumina Inc
208.32-19.11-8.40%
ALNY
Alnylam Pharmaceuticals Inc
233.85+4.46+1.94%
GMAB
Genmab A/S
37.01-0.69-1.83%
INCY
Incyte Corp
73.99+0.23+0.31%
SYNH
Syneos Health Inc
68.88-0.58-0.83%